
|Articles|October 1, 2021
Pharmacy Clinical Pearl of the Day: Schizophrenia Disease
Author(s)Saro Arakelians, PharmD
Schizophrenia may result in some combination of hallucinations, delusions, and extremely disordered thinking and behavior.
Advertisement
Clinical Pearl of the Day: Schizophrenia Disease
Schizophrenia is a serious mental disorder in which people interpret reality abnormally.
Insight:
- Disease: Schizophrenia may result in some combination of hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning and can be disabling.
- Symptoms include delusions, hallucinations, disorganized speech and thinking, abnormal motor behavior, and negative symptoms.
- Risk factors include family history of schizophrenia, exposure to toxins before birth (through mom), taking psychoactive, and psychotropic drugs.
- Treatment includes second-generation antipsychotics including: Abilify, Saphris, Rexulti, Vraylar, Clozaril, Fanapt, Latuda, Zyprexa, Invega, Seroquel, Risperdal, and Geodon. Also, first-generation antipsychotics, such as chlorpromazine, fluphenazine, haloperidol, and perphenazine. The provider can also prescribe long-acting injectable antipsychotics such as Abilify Maintena, Aristada, Fluphenazine decanoate, Haloperidol decanoate, Invega Sustenna, Invega Trinza, Risperdal Consta and Perseris.
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
5








































































































































